Green and black tea in relation to gynecologic cancers-Reference-Cited by-同舟云学术

Green and black tea in relation to gynecologic cancers

Published:2011-05-19 Issue:6 Volume:55 Page:931-940
ISSN:1613-4125
Container-title:Molecular Nutrition & Food Research
language:en
Short-container-title:Mol. Nutr. Food Res.

Author:

Butler Lesley M.,Wu Anna H.

Funder

California Breast Cancer Research Program and the WHH Foundation

Publisher

Wiley

Subject

Food Science,Biotechnology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mnfr.201100058/fullpdf

Reference64 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J. Clin.,2005

2. World Cancer Research Fund/American Institute for Cancer Research 2007

3. Prevention of cervical, vaginal, and vulval cancers: role of the quadrivalent human papillomavirus (6, 11, 16, 19) recombinant vaccine;Diaz;Int. J. Womens Health,2009

4. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors;Smith;Obstet. Gynecol.,2009

5. Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells: evidence for the endothelin-1 as a potential target;Spinella;Exp. Biol. Med.,2006

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Scoping Review of Complementary and Alternative Medicine for Human Papillomavirus Infections and Cervical Dysplasia;Journal of Lower Genital Tract Disease;2024-05-13

2. Sex differences in the benefit of tea consumption: A critical summation of the epidemiological evidence;Food Bioscience;2024-04

3. The Power of Antioxidant: TEA CATECHIN AND BODY OXIDATIVE STRESS;The Power of Antioxidants - Unleashing Nature's Defense Against Oxidative Stress [Working Title];2024-03-26

4. Medicinal Plants in Controlling and Treatment of Cutaneous Viral Diseases: Ethnopharmacology, Chemistry, and Clinical and Preclinical Studies;Reference Series in Phytochemistry;2023-11-01

5. EGCG attenuate EGF triggered matrix abundance and migration in HPV positive and HPV negative cervical cancer cells;Medical Oncology;2023-08-07